Pseudomonas aeruginosa thrives in multiple environments and is capable of causing life-threatening infections in immunocompromised patients. RsmA is a posttranscriptional regulator that controls virulence factor production and biofilm formation. In this study, we investigated the expression and activity of rsmA and the protein that it encodes, RsmA, in P. aeruginosa mucA mutant strains, which are common in chronic infections. We determined that AlgU regulates a previously unknown rsmA promoter in P. aeruginosa. Western blot analysis confirmed that AlgU controls rsmA expression in both a laboratory strain and a clinical isolate. RNase protection assays confirmed the presence of two rsmA transcripts and suggest that RpoS and AlgU regulate rsmA expression. Due to the increased amounts of RsmA in mucA mutant strains, a translational leader fusion of the RsmA target, tssA1, was constructed and tested in mucA, algU, retS, gacA, and rsmA mutant backgrounds to examine posttranscriptional activity. From these studies, we determined that RsmA is active in mucA22 mutants, suggesting a role for RsmA in mucA mutant strains. Taken together, we have demonstrated that AlgU controls rsmA transcription and is responsible for RsmA activity in mucA mutant strains. We propose that RsmA is active in P. aeruginosa mucA mutant strains and that RsmA also plays a role in chronic infections.
IMPORTANCEP. aeruginosa causes severe infections in immunocompromised patients. The posttranscriptional regulator RsmA is known to control virulence and biofilm formation. We identify a new rsmA promoter and determine that AlgU is important in the control of rsmA expression. Mutant mucA strains that are considered mucoid were used to confirm increased rsmA expression from the AlgU promoter. We demonstrate, for the first time, that there is RsmA activity in mucoid P. aeruginosa strains. Our work suggests that RsmA may play a role during chronic infections as well as acute infections.
Pseudomonas aeruginosa produces a myriad of virulence factors and can cause both acute and chronic infections (1, 2). To survive and persist, P. aeruginosa must coordinate gene expression in response to changing environmental conditions. Global regulatory networks respond to changing environmental conditions to allow the physiological changes necessary for survival to be made. The P. aeruginosa genome encodes many global regulatory systems, including posttranscriptional regulators, such as RsmA. RsmA is important in regulating several virulence factors involved in acute and chronic infections (3).Acute infections are characterized by motility and expression of the type III secretion system (4). RsmA positively regulates both motility and type III secretion system expression (4-6). A defining characteristic of chronic infections is biofilm formation, which includes the production of exopolysaccharides, such as alginate, and the type VI secretion system (T6SS) (7,8). RsmA is a negative regulator of the exopolysaccharide gene psl and the first hemolysin-coregulated se...